1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    


























































































































    Effects of Age on the Glucose Metabolic Changes in Mild Cognitive Impairment | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleFunctional

  
      
Open Access

  
      
Effects of Age on the Glucose Metabolic Changes in Mild Cognitive Impairment
  
    	
K. Kantarci, M.L. Senjem, V.J. Lowe, H.J. Wiste, S.D. Weigand, B.J. Kemp, A.R. Frank, M.M. Shiung, B.F. Boeve, D.S. Knopman, R.C. Petersen and C.R. Jack

  
    	
American Journal of Neuroradiology August 2010,  31 (7) 1247-1253; DOI: https://doi.org/10.3174/ajnr.A2070 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. Thal  LJ, 
    2. Kantarci  K, 
    3. Reiman  EM, 
    4. et al
    . The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis Assoc Disord  2006;20:6–15
    CrossRefPubMedWeb of Science
  2. 2.↵


    1. Petersen  RC, 
    2. Stevens  JC, 
    3. Ganguli  M, 
    4. et al
    . Practice parameter: early detection of dementia—mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology  2001;56:1133–42
    Abstract/FREE Full Text
  3. 3.↵


    1. Chetelat  G, 
    2. Desgranges  B, 
    3. de la Sayette  V, 
    4. et al
    . Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology  2003;60:1374–77
    Abstract/FREE Full Text
  4. 4.↵


    1. De Santi  S, 
    2. de Leon  MJ, 
    3. Rusinek  H, 
    4. et al
    . Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging  2001;22:529–39
    CrossRefPubMedWeb of Science
  5. 5.↵


    1. Drzezga  A, 
    2. Lautenschlager  N, 
    3. Siebner  H, 
    4. et al
    . Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging  2003;30:1104–13
    CrossRefPubMedWeb of Science
  6. 6.↵


    1. Minoshima  S, 
    2. Giordani  B, 
    3. Berent  S, 
    4. et al
    . Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol  1997;42:85–94
    CrossRefPubMedWeb of Science
  7. 7.↵


    1. Nestor  PJ, 
    2. Fryer  TD, 
    3. Smielewski  P, 
    4. et al
    . Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol  2003;54:343–51
    CrossRefPubMedWeb of Science
  8. 8.↵


    1. Mosconi  L, 
    2. Brys  M, 
    3. Glodzik-Sobanska  L, 
    4. et al
    . Early detection of Alzheimer's disease using neuroimaging. Exp Gerontol  2007;42:129–38
    CrossRefPubMedWeb of Science
  9. 9.↵


    1. Kim  EJ, 
    2. Cho  SS, 
    3. Jeong  Y, 
    4. et al
    . Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain  2005;128:1790–801
    Abstract/FREE Full Text
  10. 10.↵


    1. Sakamoto  S, 
    2. Ishii  K, 
    3. Sasaki  M, 
    4. et al
    . Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease. J Neurol Sci  2002;200:27–32
    CrossRefPubMedWeb of Science
  11. 11.↵


    1. Matsunari  I, 
    2. Samuraki  M, 
    3. Chen  WP, 
    4. et al
    . Comparison of 18F-FDG-PET and optimized voxel-based morphometry for detection of Alzheimer's disease: aging effect on diagnostic performance. J Nucl Med  2007;48:1961–70
    Abstract/FREE Full Text
  12. 12.↵


    1. Petersen  RC, 
    2. Kokmen  E, 
    3. Tangalos  E, 
    4. et al
    . Mayo Clinic Alzheimer's Disease Patient Registry. Aging (Milano)  1990;2:408–15
    PubMed
  13. 13.↵


    1. Kantarci  K, 
    2. Petersen  RC, 
    3. Przybelski  SA, 
    4. et al
    . Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. Arch Neurol  2008;65:1621–28
    CrossRefPubMedWeb of Science
  14. 14.↵


    1. Murray  ME, 
    2. Shiung  MM, 
    3. Weigand  SD, 
    4. et al
    . Mayo MRI visual grading scale: validation studies.
In: Proceedings of the 37th Annual Meeting of the Society for Neuroscience,San Diego, California. November 3–7, 2007
  15. 15.↵


    1. Tzourio-Mazoyer  N, 
    2. Landeau  B, 
    3. Papathanassiou  D, 
    4. et al
    . Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage  2002;15:273–89
    CrossRefPubMedWeb of Science
  16. 16.↵


    1. Hoffman  JM, 
    2. Welsh-Bohmer  KA, 
    3. Hanson  M, 
    4. et al
    . FDG-PET imaging in patients with pathologically verified dementia. J Nucl Med  2000;41:1920–28
    Abstract/FREE Full Text
  17. 17.↵


    1. Jagust  W, 
    2. Reed  B, 
    3. Mungas  D, 
    4. et al
    . What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology  2007;69:871–77
    Abstract/FREE Full Text
  18. 18.↵


    1. Silverman  DH, 
    2. Small  GW, 
    3. Chang  CY, 
    4. et al
    . Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA  2001;286:2120–27
    CrossRefPubMedWeb of Science
  19. 19.↵


    1. Vemuri  P, 
    2. Whitwell  JL, 
    3. Kantarci  K, 
    4. et al
    . Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage. Neuroimage  2008;42:559–67. Epub 2008 May 20
    CrossRefPubMedWeb of Science
  20. 20.↵


    1. Ashburner  J, 
    2. Friston  KJ
    . Unified segmentation. Neuroimage  2005;26:839–51
    CrossRefPubMedWeb of Science
  21. 21.↵


    1. Meltzer  CC, 
    2. Kinahan  PE, 
    3. Greer  PJ, 
    4. et al
    . Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med  1999;40:2053–65
    Abstract/FREE Full Text
  22. 22.↵


    1. Sun  FT, 
    2. Schriber  RA, 
    3. Greenia  JM, 
    4. et al
    . Automated template-based PET region of interest analyses in the aging brain. Neuroimage  2007;34:608–17
    CrossRefPubMedWeb of Science
  23. 23.↵


    1. Vemuri  P, 
    2. Gunter  JL, 
    3. Senjem  ML, 
    4. et al
    . Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage  2008;39:1186–97
    CrossRefPubMedWeb of Science
  24. 24.↵


    1. Roberts  RO, 
    2. Geda  YE, 
    3. Knopman  DS, 
    4. et al
    . The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology  2008;30:58–69. Epub 2008 Feb 7
    CrossRefPubMedWeb of Science
  25. 25.↵


    1. Anchisi  D, 
    2. Borroni  B, 
    3. Franceschi  M, 
    4. et al
    . Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol  2005;62:1728–33
    CrossRefPubMedWeb of Science
  26. 26.↵


    1. Bigio  EH, 
    2. Hynan  LS, 
    3. Sontag  E, 
    4. et al
    . Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis. Neuropathol Appl Neurobiol  2002;28:218–27
    CrossRefPubMedWeb of Science
  27. 27.↵


    1. Bennett  DA, 
    2. Wilson  RS, 
    3. Schneider  JA, 
    4. et al
    . Natural history of mild cognitive impairment in older persons. Neurology  2002;59:198–205
    Abstract/FREE Full Text
  28. 28.↵


    1. Jicha  GA, 
    2. Parisi  JE, 
    3. Dickson  DW, 
    4. et al
    . Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol  2006;63:674–81
    CrossRefPubMedWeb of Science
  29. 29.↵


    1. Morris  JC, 
    2. Price  AL
    . Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci  2001;17:101–18
    CrossRefPubMedWeb of Science
  30. 30.↵


    1. Petersen  RC, 
    2. Parisi  JE, 
    3. Dickson  DW, 
    4. et al
    . Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol  2006;63:665–72
    CrossRefPubMedWeb of Science
  31. 31.↵


    1. Storandt  M, 
    2. Grant  EA, 
    3. Miller  JP, 
    4. et al
    . Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology  2006;67:467–73
    Abstract/FREE Full Text
  32. 32.↵


    1. Schneider  JA, 
    2. Arvanitakis  Z, 
    3. Bang  W, 
    4. et al
    . Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology  2007;69:2197–204
    Abstract/FREE Full Text
  33. 33.↵


    1. Seo  SW, 
    2. Cho  SS, 
    3. Park  A, 
    4. et al
    . Subcortical vascular versus amnestic mild cognitive impairment: comparison of cerebral glucose metabolism. J Neuroimaging  2009;19:213–9. Epub 2009 Nov 3
    CrossRefPubMedWeb of Science
  34. 34.↵


    1. Savva  GM, 
    2. Wharton  SB, 
    3. Ince  PG, 
    4. et al
    . Age, neuropathology, and dementia. N Engl J Med  2009;360:2302–09
    CrossRefPubMedWeb of Science
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Effects of Age on the Glucose Metabolic Changes in Mild Cognitive Impairment
  
    	
K. Kantarci, M.L. Senjem, V.J. Lowe, H.J. Wiste, S.D. Weigand, B.J. Kemp, A.R. Frank, M.M. Shiung, B.F. Boeve, D.S. Knopman, R.C. Petersen, C.R. Jack

  
    	
 American Journal of Neuroradiology Aug 2010, 31 (7) 1247-1253; DOI: 10.3174/ajnr.A2070 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement